Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence
Condition: Esophageal Malignant Neoplasm, Local Recurrence Interventions: Drug: Procedural death 1; Drug: Capecitabine; Radiation: Radiotherapy; Drug: Placebo Sponsor: The First Affiliated Hospital of Henan University of Science and Technology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Esophagus Cancer | Hospitals | Immunotherapy | Research | Science | Study | Xeloda